Samsung Biologics to open $2B drug manufacturing plant

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by click on this link.

Check out the complete post here.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this content? View our policies by clicking here.

The plant is set to have to do with 2,475,700 square feet, making it the largest on the planet.

Maia Anderson –
Thursday, September 3rd, 2020
Print|Email.

Samsung Biologics CEO Kim Tae-han said the plant was initially going to be much smaller sized, but the company pressed for a growth after seeing the increase in demand for COVID-19 treatments. Last quarter, the drugmaker saw production orders nearly triple over the previous year to $1.5 billion, the Journal reported..

Samsungs drugmaker affiliate, called Samsung Biologics, is preparing to build a $2 billion drug factory to be completed in 2022, The Wall Street Journal reported..

Samsung said it wishes to catch an “unprecedented increase in need” triggered by the COVID-19 pandemic, according to the Journal. The pandemic has actually likewise exposed global dependence on China and India for drug production, which can threaten drug supply chains and trigger scarcities..

More articles on drug store: After recalls, FDA concerns guidance on avoiding carcinogens in drugs2nd FDA appointee ousted as agency deals with criticism from medical communityUS decision to abstain from WHO-backed vaccine initiative awkward, self-defeating and inconsistent, specialist says.

Samsung Biologics makes drugs for some of the worlds biggest drugmakers, including Bristol Myers Squibb and Roche, the Journal reported..